FDA Import Refusal E7E-1026048-2/4/6 — Eli Lilly & Company
The FDA refused shipment E7E-1026048-2/4/6 from Eli Lilly & Company (United States) on Apr 6, 2012. The refused product falls under Drugs and Biologics — INSULIN LISPRO PROTAMINE (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 6, 2012
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 61PDK58 INSULIN LISPRO PROTAMINE (ANTI-DIABETIC)
- Charges
- 118,75